(Q44296616)

English

A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Isabelle Ray-Coquard

3

object named as

Isabelle Ray-Coquard

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Béatrice Weber

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Rémy Largillier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Gabriel Yazbek

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jérôme Meunier

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jérôme Alexandre

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jérôme Dauba

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Dominique Spaeth

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Rémy Delva

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Eric Pujade-Lauraine

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Laure Copel

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

GINECO group, France

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

19 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1947-1954

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

https://scigraph.springernature.com/pub.10.1007/s00520-013-1748-0

0 references

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

The taxanes: toxicity and quality of life considerations in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Erythropoietin both protects from and reverses experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Evaluation of the Spanish version of the DASH and carpal tunnel syndrome health-related quality-of-life instruments: cross-cultural adaptation process and reliability

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

The Spanish National Institutes of Health-Chronic Prostatitis Symptom Index: translation and linguistic validation

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Greek versions of the Oswestry and Roland-Morris Disability Questionnaires

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Clinical significance of patient-reported questionnaire data: another step toward consensus.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growth

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1748-0

21 January 2018

French-language adaptation of an evaluation test of knowledge meant for insulin-dependent children: methodology and value for research in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of advanced ovarian cancer consensus summary. Advanced Ovarian Cancer Consensus Faculty.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of erythropoietin therapy on polyneuropathy in predialytic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy-induced peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Erythropoietin and cisplatin-induced neuropathies in cancer patients]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23420555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-013-1748-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420555%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44296616&oldid=2109247856"